Publication | Closed Access
The Chemotherapy of Experimental Tuberculosis. III. The Synthesis of Thiosemicarbazones and Related Compounds<sup>1,2</sup>
97
Citations
0
References
1951
Year
Altmetric Attention ScorePharmacotherapyAntimicrobial ChemotherapyPharmaceutical ChemistryMedicinal ChemistryPulmonary TuberculosisMolecular SciencesBiochemistryExperimental TuberculosisTuberculosisSocial Media PresenceAntibacterial AgentDrug DevelopmentPharmacologyNatural Product SynthesisNatural SciencesMedicineDrug DiscoveryPharmaceutical Research
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTThe Chemotherapy of Experimental Tuberculosis. III. The Synthesis of Thiosemicarbazones and Related Compounds1,2Jack Bernstein, Harry L. Yale, Kathryn Losee, Mary Holsing, Joseph Martins, and W. A. LottCite this: J. Am. Chem. Soc. 1951, 73, 3, 906–912Publication Date (Print):March 1, 1951Publication History Published online1 May 2002Published inissue 1 March 1951https://pubs.acs.org/doi/10.1021/ja01147a007https://doi.org/10.1021/ja01147a007research-articleACS PublicationsRequest reuse permissionsArticle Views829Altmetric-Citations88LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts